{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:57:06Z","timestamp":1781107026785,"version":"3.54.1"},"reference-count":28,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1297\/cpe.15.101","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T14:59:38Z","timestamp":1154530778000},"page":"101-107","source":"Crossref","is-referenced-by-count":5,"title":["Beneficial Effect of Oral Bisphosphonate Treatment on Bone Loss Induced by Chronic Administration of Furosemide without Alteration of Its Administration and Urinary Calcium Loss"],"prefix":"10.1297","volume":"15","author":[{"given":"Takuo","family":"Kubota","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Namba","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine"},{"name":"The First Department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Dentistry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Kurotobi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigetoyo","family":"Kogaki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Hirai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Kitaoka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ozono","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Abrams SA, Atkinson SA. Calcium, magnesium, phosphorus and vitamin D fortification of complementary foods. J Nutr 2003;133:2994S-9S.","DOI":"10.1093\/jn\/133.9.2994S"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Iso H, Date C, Noda H, Yoshimura T, Tamakoshi A; JACC Study Group. Frequency of food intake and estimated nutrient intake among men and women: the JACC Study. J Epidemiol 2005;15(Suppl 1):S24-S42.","DOI":"10.2188\/jea.15.S24"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pettifor JM. Nutritional rickets: deficiency of vitamin D, calcium, or both? Am J Clin Nutr 2004;80(Suppl):1725S-9S.","DOI":"10.1093\/ajcn\/80.6.1725S"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fitzpatrick S, Sheard NF, Clark NG, Ritter ML. Vitamin D-deficient rickets: a multifactorial disease. Nutr Rev 2000;58:218-22.","DOI":"10.1111\/j.1753-4887.2000.tb01867.x"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1297\/cpe.15.23"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Prandota J. Clinical pharmacology of furosemide in children: a supplement. Am J Ther 2001;8:275-89.","DOI":"10.1097\/00045391-200107000-00010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Constant J. Pearls and pitfalls in the use and abuse of diuretics for chronic congestive heart failure. Cardiology 1999;92:156-61.","DOI":"10.1159\/000006965"},{"key":"8","unstructured":"8. Stein MS, Scherer SC, Walton SL, Gilbert RE, Ebeling PR, Flicker L, et al. Risk factors for secondary hyperparathyroidism in a nursing home population Clin Endocrinol (Oxf) 1996;44:375-83."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Venkataraman PS, Han BK, Tsang RC, Daugherty CC. Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide therapy. Am J Dis Child 1983;137:1157-61.","DOI":"10.1001\/archpedi.1983.02140380017006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Messerli FH, Grossman E. Therapeutic controversies in hypertension. Semin Nephrol 2005;25:227-35.","DOI":"10.1016\/j.semnephrol.2005.02.007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med 2005;353:595-603.","DOI":"10.1056\/NEJMcp043801"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Delmas PD. The use of bisphosphonates in the treatment of osteoporosis. Curr Opin Rheumatol 2005;17:462-6.","DOI":"10.1097\/01.bor.0000163448.51661.87"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Raisz LG. Clinical practice. Screening for osteoporosis. N Engl J Med 2005;353:164-71.","DOI":"10.1056\/NEJMcp042092"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Geusens PP. Review of guidelines for testing and treatment of osteoporosis. Curr Osteoporos Rep 2003;1:59-65.","DOI":"10.1007\/s11914-003-0010-y"},{"key":"15","unstructured":"15. Rauch F, Glorieux FH. Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long? Ann Med 2005;37:295-302."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Maricic M. Glucocorticoid-induced osteoporosis: treatment options and guidelines. Curr Osteoporos Rep 2005;3:25-9.","DOI":"10.1007\/s11914-005-0024-8"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.2174\/1381612033453640"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1007\/s007740170001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Rio LD, Carrascosa A, Pons F, Gusinye M, Yeste D, Domenech FM. Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: Changes related to age, sex, and puberty. Pediatr Res1994;35:362-4.","DOI":"10.1203\/00006450-199403000-00018"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hirota T, Nara M, Ohguri M, Manago E, Horota K. Effect of diet and lifestyle on bone mass in Asian young women. Am J Clin Nutr 1992;55:1168-73.","DOI":"10.1093\/ajcn\/55.6.1168"},{"key":"21","unstructured":"21. South-Paul JE. Osteoporosis: part I. Evaluation and assessment. Am Fam Physician 2001;63:897-904, 908."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nakamura K, Ueno K, Nishiwaki T, Okuda Y, Saito T, Tsuchiya Y, et al. Nutrition, mild hyperparathyroidism, and bone mineral density in young Japanese women. Am J Clin Nutr 2005;82:1127-33.","DOI":"10.1093\/ajcn\/82.5.1127"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nishio K, Mukae S, Aoki S, Itoh S, Konno N, Ozawa K, et al. Congestive heart failure is associated with the rate of bone loss. J Intern Med 2003;253:439-46.","DOI":"10.1046\/j.1365-2796.2003.01130.x"},{"key":"24","unstructured":"24. Takahashi Y, Minamitani K, Kobayashi Y, Minagawa M, Yasuda T, Niimi H. Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism. J Clin Endocrinol Metab 1996;81:1248-53."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bone HG, Hosking D, Devogelaer J-P, Tucci JR, Emkey RD, Tonino RP, et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 2004;350:1189-99.","DOI":"10.1056\/NEJMoa030897"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CYC. Severely suppressed bone turnover: A potential complication of alendronate therapy. J Clin Endocrinol Metab 2005;90:1294-301.","DOI":"10.1210\/jc.2004-0952"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Rossen CJ, Brown S. Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med 2003;348:1503-4.","DOI":"10.1056\/NEJM200304103481521"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Biswas PN, Wilton LV, Shakir SAW. Pharmacovigilance study of alendronate in England. Osteoporos Int 2003;14:507-14.","DOI":"10.1007\/s00198-003-1399-y"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/cpe\/15\/3\/15_3_101\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T22:19:13Z","timestamp":1617142753000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/cpe\/15\/3\/15_3_101\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.15.101","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}